Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety and Proof of Principle Study of ATX-GD-59 in Male and Female Subjects With Graves' Disease Not Currently Treated With Anti-thyroid Therapy: An Open Label Study, With an Upward Titration Over Five Dose Levels Administered by Intradermal Injection.

Next Previous
X
Search
Trial Profile

Safety and Proof of Principle Study of ATX-GD-59 in Male and Female Subjects With Graves' Disease Not Currently Treated With Anti-thyroid Therapy: An Open Label Study, With an Upward Titration Over Five Dose Levels Administered by Intradermal Injection.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 03 Oct 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ATX-GD 59 (Primary)
  • Indications Graves' disease
  • Focus Adverse reactions; First in man
  • Sponsors Apitope Technology

    • Most Recent Events

    • 13 Sep 2019 According to an Apitope Technology media release, the company announced that this first in human clinical trial for the treatment of Graves' disease funded by the European Union (DAVIAD) has been published as a "Success Story" on the European Union website. The article entitled 'New treatment on the horizon for Graves' disease can be viewed in the following link: https://ec.europa.eu/research/infocentre/article_en.cfm?artid=50625
    • 16 Apr 2018 According to an Apitope Technology media release, company has announced positive results from this trial.This study met the primary endpoint to assess the safety and tolerability of ATX-GD-59 in 12 patients with Graves' disease.
    • 19 Feb 2018 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top